10 related articles for article (PubMed ID: 38745830)
1. Topical steroid withdrawal: an emerging clinical problem.
Brookes TS; Barlow R; Mohandas P; Bewley A
Clin Exp Dermatol; 2023 Aug; 48(9):1007-1011. PubMed ID: 37119282
[TBL] [Abstract][Full Text] [Related]
2. JAK inhibitors in the treatment of atopic dermatitis.
Chovatiya R; Paller AS
J Allergy Clin Immunol; 2021 Oct; 148(4):927-940. PubMed ID: 34437922
[TBL] [Abstract][Full Text] [Related]
3. Steroid Phobia: Is There a Basis? A Review of Topical Steroid Safety, Addiction and Withdrawal.
Tan SY; Chandran NS; Choi EC
Clin Drug Investig; 2021 Oct; 41(10):835-842. PubMed ID: 34409577
[TBL] [Abstract][Full Text] [Related]
4. Topical corticosteroid withdrawal ('steroid addiction'): an update of a systematic review.
Hwang J; Lio PA
J Dermatolog Treat; 2022 May; 33(3):1293-1298. PubMed ID: 33499686
[TBL] [Abstract][Full Text] [Related]
5. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases.
Schwartz DM; Bonelli M; Gadina M; O'Shea JJ
Nat Rev Rheumatol; 2016 Jan; 12(1):25-36. PubMed ID: 26633291
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
Hajar T; Leshem YA; Hanifin JM; Nedorost ST; Lio PA; Paller AS; Block J; Simpson EL;
J Am Acad Dermatol; 2015 Mar; 72(3):541-549.e2. PubMed ID: 25592622
[TBL] [Abstract][Full Text] [Related]
7. Topical steroid withdrawal treated with ruxolitinib cream.
Shea M; Grinich E; Simpson E
JAAD Case Rep; 2024 Jun; 48():5-7. PubMed ID: 38745830
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
